← Back to Search

Behavioural Intervention

Verasense for Osteoarthritis

N/A
Waitlist Available
Led By Jeffrey Geller, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary total knee replacement
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will compare the use of a new technology, Verasense, to manual soft tissue balancing in total knee arthroplasty (TKA). The primary outcomes of interest are patient-reported outcomes and knee range of motion at 3 months, 6 months, 1 year, and 2 years.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Veterans RAND12 Item Health Survey
Secondary outcome measures
Ambulation (distance)
KOOS Knee Survey
Range of motion
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sensor GroupExperimental Treatment1 Intervention
Patients will undergo total knee replacement surgery with Verasense assisted balancing technology.
Group II: Non-Sensor GroupActive Control1 Intervention
Patients will undergo standard total knee replacement surgery without Verasense assisted balancing technology.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,428 Previous Clinical Trials
2,459,990 Total Patients Enrolled
6 Trials studying Osteoarthritis
1,025 Patients Enrolled for Osteoarthritis
Jeffrey Geller, MDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
155 Total Patients Enrolled
1 Trials studying Osteoarthritis
155 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to participate in this experiment?

"To be eligible to take part in this clinical trial, participants must have had a primary total knee replacement and range between 18-85 years old with osteoarthritis of the knee. A maximum of 130 people will partake."

Answered by AI

Are any additional participants being accepted for this experiment?

"Data from clinicaltrials.gov reveals that this medical study, initially posted December 20th 2017 and most recently updated September 30th 2021, is not currently recruiting patients for trial participation. Nevertheless, there are 456 other trials searching for participants at the present moment."

Answered by AI

Are participants of this experiment required to be 18 years or older?

"The minimum age of admission to this medical trial is 18 and the oldest potential participant can be no greater than 85 years old."

Answered by AI
Recent research and studies
~18 spots leftby Apr 2025